Zobrazeno 1 - 3
of 3
pro vyhledávání: '"E. A. Zamora-Tehozol"'
Autor:
V. Rivera Teran, D. Vega-Morales, S. Sicsik, F. Irazoque-Palazuelos, M. A. Saavedra, J. C. Casasola, S. Carrilo, A. Peña, A. Castillo Ortiz, O. E. Muñoz-Monroy, S. Duran Barragan, A. Ramos, L. F. Valdés Corona, E. Torres Valdéz, A. Paz, E. A. Zamora-Tehozol, A. Torres, S. Mendieta, D. X. Xibille Friedmann, F. Guerrero, N. Santana, M. Vazquez, C. Zepeda, M. Rivera, K. Alvarado, D. Alpizar-Rodriguez
Publikováno v:
Annals of the Rheumatic Diseases. 81:1824.1-1824
BackgroundPatients with rheumatic diseases (RD) have a higher risk of developing infections due to disease and immunosupressor treatment factors1. Biologic disease -modifying antirheumatic drugs (bDMARD) have been associated with the development of o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8dd305d654d32e63cd42b148b17f54b1
https://doi.org/10.1136/annrheumdis-2022-eular.2198
https://doi.org/10.1136/annrheumdis-2022-eular.2198
Autor:
V. Rivera Teran, D. Vega-Morales, S. Sicsik, F. Irazoque-Palazuelos, M. A. Saavedra, J. C. Casasola, S. Carrilo, A. Peña, A. Castillo Ortiz, O. E. Muñoz-Monroy, S. Duran Barragan, A. Ramos, L. F. Valdés Corona, E. Torres Valdéz, A. Paz, E. A. Zamora-Tehozol, A. Torres, S. Mendieta, D. X. Xibille Friedmann, F. Guerrero, N. Santana, M. Vazquez, C. Zepeda, M. Rivera, K. Alvarado, D. Alpizar-Rodriguez
Publikováno v:
Annals of the Rheumatic Diseases. 81:1068-1068
BackgroundRheumatic diseases prevalence and characteristics in Mexico may vary depending on the country´s region1. To acknowledge these differences is needed to develop focused strategies for early diagnosis and treatment2.ObjectivesIdentify the soc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3eb0429b88becb7f3b3cca49edc0e793
https://doi.org/10.1136/annrheumdis-2022-eular.4842
https://doi.org/10.1136/annrheumdis-2022-eular.4842
Autor:
V. Rivera Teran, D. Vega-Morales, S. Sicsik, F. Irazoque-Palazuelos, M. A. Saavedra, J. C. Casasola, S. Carrilo, A. Peña, A. Castillo Ortiz, O. E. Muñoz-Monroy, S. Duran Barragan, A. Ramos, L. F. Valdés Corona, E. Torres Valdéz, A. Paz, E. A. Zamora-Tehozol, D. X. Xibille Friedmann, F. Guerrero, N. Santana, M. Vazquez, C. Zepeda, M. Rivera, K. Alvarado, D. Alpizar-Rodriguez
Publikováno v:
Annals of the Rheumatic Diseases. 81:1836-1836
BackgroundDecrease treatment persistence in rheumatoid arthritis (RA) patients has been associated with several factors, including number of previous biological DMARDs (bDMARDs), female gender and higher disease activity or lower function at baseline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20fb07962d408667c9ccd62e1a615d69
https://doi.org/10.1136/annrheumdis-2022-eular.5000
https://doi.org/10.1136/annrheumdis-2022-eular.5000